These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6827566)

  • 1. Synthesis and antiarrhythmic activity of new [(dialkylamino)alkyl]pyridylacetamides.
    Bernhart CA; Condamine C; Demarne H; Roncucci R; Gagnol JP; Gautier PJ; Serre MA
    J Med Chem; 1983 Mar; 26(3):451-5. PubMed ID: 6827566
    [No Abstract]   [Full Text] [Related]  

  • 2. Compounds related to 4-disopropylamino-2-phenyl-2(2-pyridyl)butyramide. Their synthesis and antiarrhythmic activity.
    Yen CH; Lowrie HS; Dean RR
    J Med Chem; 1974 Nov; 17(11):1131-5. PubMed ID: 4412561
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular orbital index-activity relationship between atrial antiarrhythmic activity and disopyramide derivatives.
    Lin TK; Chien YW; Desai HB; Yonan PK
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2739-43. PubMed ID: 1017110
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and antiarrhythmic activity of alpha, alpha-bis[(dialkylamino)alkyl]phenylacetamides.
    Yonan PK; Novotney RL; Woo CM; Prodan KA; Hershenson FM
    J Med Chem; 1980 Oct; 23(10):1102-8. PubMed ID: 7420355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.
    Mathur PP
    Am Heart J; 1972 Dec; 84(6):764-70. PubMed ID: 4150336
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G; Singh BN
    Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantum statistical calculation for the correlation of biological activity and chemical structure. 3. Diisopyramide phosphate and related compounds as antiarrhythmic agents.
    Lin TK; Chien YW; Dean RR; Dutt JE; Sause HW; Yen CH; Yonan PK
    J Med Chem; 1974 Jul; 17(7):751-3. PubMed ID: 4836408
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative comparison of the anticholinergic and antiarrhytmic actions of disopyramide and quinidine.
    Pérez A; Ledea N; Hermández K; Garcia-Barreto D
    Pol J Pharmacol Pharm; 1977; 29(5):527-32. PubMed ID: 593967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effects of disopyramide and hydroquinidine in animals].
    Lisin N; Carlier J
    Arch Mal Coeur Vaiss; 1973 Oct; 66(10):1329-35. PubMed ID: 4207476
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
    Junien JL; Lakatos CR; Tine J
    Arzneimittelforschung; 1974 Nov; 24(11):1743-7. PubMed ID: 4141258
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative antidysrhythmic profiles of bepridil, amiodarone and disopyramide in the guinea-pig and dog.
    Labrid C; Leinot M; Beaughard M; Basiez M; Duchene-Marullaz P
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):87-97. PubMed ID: 6971633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some pharmacological effects of disopyramide and a metabolite.
    Baines MW; Davies JE; Kellett DN; Munt PL
    J Int Med Res; 1976; 4(1 Suppl):5-7. PubMed ID: 193744
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and anticholinergic properties of the enantiomers of 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide, the mono-N-dealkylated metabolite of disopyramide.
    Nelson WL; Sneed CK; Giacomini KM; Giacomini JC; Stauss J; Blaschke TF; Cox BM
    J Med Chem; 1981 May; 24(5):614-7. PubMed ID: 7241519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 15. Linear relationships between plasma binding and lipophilicity of disopyramide derivatives.
    Chien YW; Lambert HJ; Lin TK
    J Pharm Sci; 1975 Jun; 64(6):961-6. PubMed ID: 1133751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drugs preferentially produce conduction block at the area of slow conduction in the re-entrant circuit of canine atrial flutter: comparative study of disopyramide, flecainide, and E-4031.
    Inoue H; Yamashita T; Usui M; Nozaki A; Sugimoto T
    Cardiovasc Res; 1991 Mar; 25(3):223-9. PubMed ID: 1903082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic effect of disopyramide injected into the sinus nodal artery.
    Garcia-Barreto D; Pérez-Medina T
    Acta Physiol Acad Sci Hung; 1977; 49(3-4):231-5. PubMed ID: 755338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologically active conformation of disopyramide: evidence from apparent pKa measurements.
    Czeisler JL; el-Rashidy RM
    J Pharm Sci; 1985 Jul; 74(7):750-4. PubMed ID: 4032248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some 10-substituted 5-ethyl-10-dialkylaminoalkyl-10,11-dihydro-5H-dibenz[b,f]azepines as potential antiarrhythmic agents.
    Ellefson CR; Cusic JW
    J Med Chem; 1976 Nov; 19(11):1345-9. PubMed ID: 1003416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.